How did ACT UP influence AIDS treatment and drug approval?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

Founded in 1987, the AIDS Coalition to Unleash Power (ACT UP) played a pivotal role in transforming the U.S. government’s response to the AIDS epidemic by demanding faster drug approval and improved access to care.12

ACT UP utilized radical, nonviolent protest and civil disobedience to challenge bureaucratic inertia within the Food and Drug Administration (FDA) and the National Institutes of Health (NIH). Key influences included:13

  • Direct Action: Activists organized mass demonstrations, such as the 1988 attempt to enter FDA headquarters, to protest the agency’s slow, decadelong approval process for experimental drugs.3
  • Policy Participation: Through persistent pressure, activists—including those who had previously been barred—gained invitations to participate in NIH proceedings, allowing them to influence research priorities.3
  • Economic Pressure: The group targeted pharmaceutical companies to lower the cost of treatments. For example, a 1989 protest at the New York Stock Exchange against the high price of AZT was credited with forcing a significant price reduction.3

By shifting the focus toward patient-centered advocacy, ACT UP helped dismantle barriers to life-saving treatments and fundamentally changed how the world addressed the AIDS crisis.13